• What are the benefits of the decentralized clinical trial (DCT) model?
• What are the barriers to sites and investigators participating in DCTs?
• What support measures are critical to DCT success?
• What is the outlook for DCTs during the coming 3 – 5 years and how can sites and investigators contribute to their evolution?

Listen to a lively discussion of these questions and more, as industry experts discuss DCT and hybrid clinical trial models. Download and listen to your free podcast from Scrip, presented in partnership with ICON.